Creative Biolabs ADC Blog

Menu

Skip to content
  • Home
  • Antibody-drug Conjugates Research
  • Antibody-drug Conjugates Manufacturing
  • News

DrugLnk™ Custom Synthesis

Perfect For Business And WooCommerce WordPress Sites

Learn More

Antibody Design and Conjugation

Creative Biolabs provides the most comprehensive antibody design and conjugation services for customized antibody-drug conjugate development

Learn More

Customized ADCs

Creative Biolabs offers a variety of customized ADCs against various cancer targets for antibody-drug conjugate (ADC) development projects.

Learn More

ADC Analysis

Creative Biolabs provides a comprehensive set of in vivo& in vitro analysis services to boost your project research.

Learn More
08Feb/18

AMID Significant Progress, Robust Growth and Advancing Pipeline — Immunogen Closes Massachusetts Facility

February 8, 2018Antibody-drug Conjugates Research, Newsantibody drug conjugate pepline, antibody drug conjugatesbioadc

A leader in the expanding field of antibody-drug conjugates or ADCs for the treatment of cancer, Immunogen last week highlighted some of the company’s the operating results for 2017. Immunogen is a clinical-stage biotechnologyRead More…

Posts navigation

  • « Previous
  • 1
  • …
  • 9
  • 10
  • 11

Categories

Recent Posts

  • The Next Frontier in Oncology: Why Bispecific ADCs are Redefining Precision Medicine
  • Antibody-Drug Conjugates: A Precision Strike in Cancer Therapy
  • The Renaissance of “Magic Bullets”: Navigating the Complex Landscape of Next-Generation ADC Development
  • The Era of the “Biological Missile”: Innovations and Frontiers in Antibody-Drug Conjugate Development
  • Targeting Drug-Resistant Breast Cancer with a Novel ADC

Archives

Contact Us

USA - UK

Copyright © Creative Biolabs ADC Blog
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Home
  • Antibody-drug Conjugates Research
  • Antibody-drug Conjugates Manufacturing
  • News